PMID- 19146941 OWN - NLM STAT- MEDLINE DCOM- 20090609 LR - 20220330 IS - 1872-7573 (Electronic) IS - 0378-8741 (Linking) VI - 122 IP - 1 DP - 2009 Feb 25 TI - Anti-inflammatory activity of a water extract of Acorus calamus L. leaves on keratinocyte HaCaT cells. PG - 149-56 LID - 10.1016/j.jep.2008.12.011 [doi] AB - ETHNOPHARMACOLOGICAL RELEVANCE: Acorus calamus L., sweet flag, is a well-known medicinal plant that grows worldwide wildly along swamps, rivers, and lakes. AIM OF THE STUDY: The aim of this study was to evaluate the anti-inflammatory activity of Acorus calamus leaf (ACL) extract and to explore its mechanism of action on human keratinocyte HaCaT cells. MATERIALS AND METHODS: HaCaT cells treated with polyinosinic:polycytidylic acid (polyI:C) and peptidoglycan (PGN) induced the inflammatory reactions. The anti-inflammatory activities of ACL were investigated using RT-PCR, ELISA assay, immunoblotting, and immunofluorescence staining. RESULTS: HaCaT cells induced the pro-inflammatory cytokines, interleukin-8 (IL-8) and/or interleukin-6 (IL-6) expressions after treatment with polyI:C or PGN. ACL inhibited the expression of IL-8 and IL-6 RNA and protein levels, and attenuated the activation of NF-kappaB and IRF3 after polyI:C treatment. ACL also inhibited expression of IL-8 and activation of NF-kappaB following PGN induction. CONCLUSIONS: These results suggest that ACL inhibits the production of pro-inflammatory cytokines through multiple mechanisms and may be a novel and effective anti-inflammatory agent for the treatment of skin diseases. FAU - Kim, Hyeri AU - Kim H AD - Department of Biotechnology, BK21 Graduate Program for Biotechnology, Chonnam National University, 300 Yongbong-Dong, Buk-Gu, Gwangju 500-757, Republic of Korea. FAU - Han, Tae-Ho AU - Han TH FAU - Lee, Seong-Gene AU - Lee SG LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20081225 PL - Ireland TA - J Ethnopharmacol JT - Journal of ethnopharmacology JID - 7903310 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Interferon Regulatory Factor-3) RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (NF-kappa B) RN - 0 (Peptidoglycan) RN - 0 (Plant Extracts) RN - O84C90HH2L (Poly I-C) SB - IM MH - *Acorus MH - Anti-Inflammatory Agents/*pharmacology MH - Biological Transport/drug effects MH - Cell Proliferation/*drug effects MH - Cells, Cultured MH - Humans MH - Inflammation/chemically induced/drug therapy MH - Interferon Regulatory Factor-3/antagonists & inhibitors MH - Interleukin-6/antagonists & inhibitors MH - Interleukin-8/antagonists & inhibitors MH - Keratinocytes/cytology/*drug effects MH - NF-kappa B/antagonists & inhibitors MH - Peptidoglycan/adverse effects MH - Phytotherapy MH - Plant Extracts/*pharmacology MH - Plant Leaves MH - Poly I-C/adverse effects EDAT- 2009/01/17 09:00 MHDA- 2009/06/10 09:00 CRDT- 2009/01/17 09:00 PHST- 2008/09/24 00:00 [received] PHST- 2008/11/18 00:00 [revised] PHST- 2008/12/16 00:00 [accepted] PHST- 2009/01/17 09:00 [entrez] PHST- 2009/01/17 09:00 [pubmed] PHST- 2009/06/10 09:00 [medline] AID - S0378-8741(08)00703-4 [pii] AID - 10.1016/j.jep.2008.12.011 [doi] PST - ppublish SO - J Ethnopharmacol. 2009 Feb 25;122(1):149-56. doi: 10.1016/j.jep.2008.12.011. Epub 2008 Dec 25.